Aalborg University Hospital

PSMA PET/CT Before Salvage Radiotherapy Improves Survival in Recurrent Prostate Cancer

- A Danish nationwide study of 844 patients demonstrates that PSMA PET/CT imaging before salvage radiotherapy significantly improves overall survival rates in men with biochemically recurrent prostate cancer. - Patients who underwent PSMA PET/CT showed superior five-year survival rates of 98.1% compared to 93.8% for those who did not receive the imaging. - The study provides the first real-world evidence that PSMA PET/CT-guided treatment selection leads to improved clinical outcomes in salvage radiotherapy patients. - These findings support broader adoption of PSMA PET/CT as a standard imaging modality for treatment planning in recurrent prostate cancer cases.